Cost of asthma in the Asia-Pacific region
Authors:
- C. K. W. LaiCLC. K. W. Lai
- Y-Y. KimYKY-Y. Kim
- S-H. KuoSKS-H. Kuo
- M. SpencerMSM. Spencer
- A. E. WilliamsAWA. E. Williams
Open Access
- 2 June 2006
- journal article
- Published by European Respiratory Society (ERS) in European Respiratory Review
- Vol. 15 (98) , 10-16
Abstract
The substantial morbidity caused by asthma suggests that the disease is associated with a large economic burden. The current study analysed the burden of asthma in eight countries in the Asia-Pacific region.Responses to questions regarding resource use from a survey of people with asthma were analysed. Unit costs were obtained for each resource use element. Individual patient costs were estimated and means calculated for each country. A multivariate model was developed to identify potential predictors of resource use.Annual per-patient direct costs ranged from US$108 for Malaysia to US$1,010 for Hong Kong. When productivity costs were included, total per-patient societal costs ranged from US$184 in Vietnam to US$1,189 in Hong Kong. Urgent care costs were responsible for 18–90% of total per-patient direct costs. Overall, total per-patient direct costs were equivalent to 13% ofper capitagross domestic product and 300% ofper capitahealthcare spending. Extremes of age, greater severity of asthma, and poorer general health status were predictive of high cost.The per-patient cost of asthma in these countries is high, particularly when seen in the context of overall per-patient healthcare spending. Strategies to improve asthma control are likely to not only improve patient outcomes, but also to decrease societal costs.Keywords
This publication has 20 references indexed in Scilit:
- Worldwide severity and control of asthma in children and adults: the global asthma insights and reality surveysJournal of Allergy and Clinical Immunology, 2004
- A comprehensive study of the direct and indirect costs of adult asthmaJournal of Allergy and Clinical Immunology, 2003
- Asthma control in the Asia-Pacific region: The asthma insights and reality in Asia-Pacific studyJournal of Allergy and Clinical Immunology, 2003
- The burden of asthma with specific reference to the United StatesJournal of Allergy and Clinical Immunology, 2002
- The health economics of asthma and rhinitis. I. Assessing the economic impactJournal of Allergy and Clinical Immunology, 2001
- Trends in the cost of illness for asthma in the United States, 1985-1994Journal of Allergy and Clinical Immunology, 2000
- The economic cost of asthma in SingaporeAustralian and New Zealand Journal of Medicine, 1999
- The economic burden of asthma: direct and indirect costs in SwitzerlandEuropean Respiratory Journal, 1999
- Outcomes and cost benefits associated with the introduction of inhaled corticosteroid therapy in a medicaid population of asthmatic patientsClinical Therapeutics, 1998
- Prevalence of childhood asthma based on questionnaires and methacholine bronchial provocation test in KoreaClinical & Experimental Allergy, 1997